| N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells JK Lee, JW Phillips, BA Smith, JW Park, T Stoyanova, EF McCaffrey, ... Cancer cell 29 (4), 536-547, 2016 | 405 | 2016 |
| The prenatal origins of cancer GM Marshall, DR Carter, BB Cheung, T Liu, MK Mateos, JG Meyerowitz, ... Nature Reviews Cancer 14 (4), 277-289, 2014 | 320 | 2014 |
| Drugging MYCN through an allosteric transition in Aurora kinase A WC Gustafson, JG Meyerowitz, EA Nekritz, J Chen, C Benes, E Charron, ... Cancer cell 26 (3), 414-427, 2014 | 301 | 2014 |
| G-protein activation by a metabotropic glutamate receptor AB Seven, X Barros-Álvarez, M de Lapeyrière, MM Papasergi-Scott, ... Nature 595 (7867), 450-454, 2021 | 118 | 2021 |
| Asymmetric activation of the calcium-sensing receptor homodimer Y Gao, MJ Robertson, SN Rahman, AB Seven, C Zhang, JG Meyerowitz, ... Nature 595 (7867), 455-459, 2021 | 110 | 2021 |
| The tethered peptide activation mechanism of adhesion GPCRs X Barros-Álvarez, RM Nwokonko, A Vizurraga, D Matzov, F He, ... Nature 604 (7907), 757-762, 2022 | 99 | 2022 |
| Structure determination of inactive-state GPCRs with a universal nanobody MJ Robertson, MM Papasergi-Scott, F He, AB Seven, JG Meyerowitz, ... Nature Structural & Molecular Biology 29 (12), 1188-1195, 2022 | 89 | 2022 |
| Epithelial carbonic anhydrases facilitate PCO2 and pH regulation in rat duodenal mucosa M Mizumori, J Meyerowitz, T Takeuchi, S Lim, P Lee, CT Supuran, ... The Journal of Physiology 573 (3), 827-842, 2006 | 69 | 2006 |
| Drug discovery in the era of cryo-electron microscopy MJ Robertson, JG Meyerowitz, G Skiniotis Trends in biochemical sciences 47 (2), 124-135, 2022 | 67 | 2022 |
| Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists H Wang, F Hetzer, W Huang, Q Qu, J Meyerowitz, J Kaindl, H Hübner, ... Angewandte Chemie International Edition 61 (26), e202200269, 2022 | 50 | 2022 |
| BRAF status in personalizing treatment approaches for pediatric gliomas A Olow, S Mueller, X Yang, R Hashizume, J Meyerowitz, W Weiss, ... Clinical Cancer Research 22 (21), 5312-5321, 2016 | 48 | 2016 |
| The oxytocin signaling complex reveals a molecular switch for cation dependence JG Meyerowitz, MJ Robertson, X Barros-Álvarez, O Panova, ... Nature Structural & Molecular Biology 29 (3), 274-281, 2022 | 46 | 2022 |
| Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 D Feyaerts, J Hedou, J Gillard, H Chen, ES Tsai, LS Peterson, K Ando, ... Cell Reports Medicine 3 (7), 2022 | 35 | 2022 |
| Discovery of RMC-5552, a selective bi-steric inhibitor of mTORC1, for the treatment of mTORC1-activated tumors GL Burnett, YC Yang, JB Aggen, J Pitzen, MK Gliedt, CM Semko, ... Journal of medicinal chemistry 66 (1), 149-169, 2022 | 34 | 2022 |
| Plasticity in ligand recognition at somatostatin receptors MJ Robertson, JG Meyerowitz, O Panova, K Borrelli, G Skiniotis Nature structural & molecular biology 29 (3), 210-217, 2022 | 34 | 2022 |
| Impact of magnesium on oxytocin receptor function VN Bharadwaj, J Meyerowitz, B Zou, M Klukinov, N Yan, K Sharma, ... Pharmaceutics 14 (5), 1105, 2022 | 15 | 2022 |
| Manual of clinical anesthesiology LF Chu, A Fuller Lippincott Williams & Wilkins, 2012 | 15 | 2012 |
| Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study I Núñez, J Gillard, S Fragoso-Saavedra, D Feyaerts, L Islas-Weinstein, ... Frontiers in Medicine 10, 1236702, 2023 | 12 | 2023 |
| A new “angle” on kinase inhibitor design: Prioritizing amphosteric activity above kinase inhibition JG Meyerowitz, WA Weiss, WC Gustafson Molecular & Cellular Oncology 2 (2), e975641, 2015 | 7 | 2015 |
| Large library docking identifies positive allosteric modulators of the calcium-sensing receptor F Liu, CG Wu, CL Tu, I Glenn, J Meyerowitz, AL Kaplan, J Lyu, Z Cheng, ... Science 385 (6715), eado1868, 2024 | 5 | 2024 |
Erin F. SimondsDirector at Soteria Biotherapeutics確認したメール アドレス: soteriabiotx.com